Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Why IBD 50's Top Seed, Hims & Hers, Just Crashed On Its Upbeat Earnings
Why IBD 50's Top Seed, Hims & Hers, Just Crashed On Its Upbeat Earnings · Investor's Business Daily

In This Article:

Hims stock plunged Tuesday after the compounding pharmacy issued a bullish outlook that still includes knockoff versions of semaglutide.